Tested Applications
| Positive WB detected in | HL-60 cells |
| Positive IHC detected in | human liver cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
16026-1-AP targets BCL2L2 in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag8863 Product name: Recombinant human BCL2L2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-171 aa of BC021198 Sequence: MATPASAPDTRALVADFVGYKLRQKGYVCGAGPGEGPAADPLHQAMRAAGDEFETRFRRTFSDLAAQLHVTPGSAQQRFTQVSDELFQGGPNWGRLVAFFVFGAALCAESVNKEMEPLVGQVQEWMVAYLETRLADWIHSSGGWAEFTALYGDGALEEARRLREGNWASVR Predict reactive species |
| Full Name | BCL2-like 2 |
| Calculated Molecular Weight | 193 aa, 21 kDa |
| Observed Molecular Weight | 21 kDa |
| GenBank Accession Number | BC021198 |
| Gene Symbol | BCL2L2 |
| Gene ID (NCBI) | 599 |
| RRID | AB_2827646 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q92843 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for BCL2L2 antibody 16026-1-AP | Download protocol |
| WB protocol for BCL2L2 antibody 16026-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The BCL2L2 (Bcl-xL) antibody (Cat# 16026-1-AP) has 17 citations across journals including Nature Communications, Int J Mol Sci, Cell Signal, Exp Neurol, Cancers, iScience, Front Neurosci, Eur J Pharmacol, Neural Regen Res, Oxid Med Cell Longev, Basic Clin Pharmacol Toxicol, Exp Eye Res, PLoS One, Tumour Biol, Cancer Inform, and Transl Cancer Res. Research fields span apoptosis, senescence, neurovascularization, ferroptosis, oxidative stress, and multiple cancer types.
| Species | Application | Title |
|---|---|---|
Nat Commun Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression | ||
Neural Regen Res Mechanism of piR-1245/PIWI-like protein-2 regulating Janus kinase-2/signal transducer and activator of transcription-3/vascular endothelial growth factor signaling pathway in retinal neovascularization | ||
Oxid Med Cell Longev Peptides Isolated from Yak Milk Residue Exert Antioxidant Effects through Nrf2 Signal Pathway. | ||
Eur J Pharmacol GSK-3β-mediated activation of NLRP3 inflammasome leads to pyroptosis and apoptosis of rat cardiomyocytes and fibroblasts. | ||
Int J Mol Sci Role of Orai3-Mediated Store-Operated Calcium Entry in Radiation-Induced Brain Microvascular Endothelial Cell Injury | ||
Int J Mol Sci Targeting Bcl-xL with Navitoclax Effectively Eliminates Senescent Tumor Cells That Appear Following CEP-1347-Induced Differentiation of Glioma Stem Cells |





